Related Experiment Video
Updated: Apr 14, 2026

09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.3K
Molecular Targets of Omega-3 Fatty Acids for Cancer Therapy
K Pandima Devi1, T Rajavel, G L Russo
1Department of Biotechnology, Alagappa University, Karaikudi-630 004, Tamil Nadu, India. devikasi@yahoo.com.
Anti-Cancer Agents in Medicinal Chemistry
|April 25, 2015
Summary
Omega-3 polyunsaturated fatty acids show therapeutic potential in fighting diseases. Emerging evidence highlights their anticancer effects and molecular targets, supporting their use in cancer therapy.
Area of Science:
- Nutritional Science
- Oncology
- Biochemistry
Background:
- Dietary guidelines increasingly recognize omega-3 polyunsaturated fatty acids (PUFAs) for their health benefits.
- Consumption of omega-3 PUFAs has risen, with average intake doubling in the past two decades.
- These fatty acids are found in sources like fatty fish, shellfish, and vegetable oils.
Purpose of the Study:
- To review the fundamental evidence supporting the use of omega-3 PUFAs in cancer therapy.
- To explore the molecular mechanisms and targets of omega-3 PUFAs in various cancer models.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of experimental evidence from cancer models.
- Identification of molecular targets associated with omega-3 PUFA action.
Main Results:
- A significant body of evidence supports the anticancer properties of omega-3 PUFAs.
- Molecular targets for omega-3 PUFAs have been identified in several cancer types.
- The review consolidates basic research indicating therapeutic potential.
Conclusions:
- Omega-3 PUFAs demonstrate promising anticancer effects.
- Further research into their molecular targets could lead to novel cancer treatment strategies.
- Dietary intake of omega-3 PUFAs may play a role in cancer prevention and therapy.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies
1.8K
1.8K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression
1.7K
1.7K
Cancer Therapies
10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
Cancer Therapies
3.0K
3.0K

